New Lung Cancer Treatment

FDA Approves Libtayo as Monotherapy for Advanced NSCLC

Libtayo | Lung Cancer
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]

NICE Recommends Keytruda Plus Chemo for NSCLC Treatment

Non-Small-Cell Lung Cancer (NSCLC)
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for [...]

Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment

Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. [...]

Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment

Lung Cancer Treatment
Lung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for [...]

Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment

Cancer Cell | Lung Cancer
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that [...]

New Study Identifies Drug to Boost Lung Cancer Survival Rates

Lung Cancer
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]

New EarlyCDT-Lung Blood Test for Early Detection of Lung Cancer

Blood Test | Lung Cancer
Thanks to the pioneering new blood test, lung cancer could be detected earlier. This news comes as a fresh hope for lung cancer patients. The main reason [...]

Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]

FDA Approves Tabrecta, First Targeted Therapy for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]

What to Consider Before Getting A Lung Cancer on Marijuana Medication?

Marijuana Medication | Lung Cancer
Lung cancer is one of the major causes of death, particularly in the US. It has been found that more people die because of it as compared to other types of [...]

Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients

Lung Cancer
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. [...]

Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment

lung | Lung Cancer
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating [...]

New Lung Cancer Treatment Approved By NHS Scotland

Lung Cancer
The Scottish Medicines Consortium (SMC) confirms another immunotherapy treatment in combination with chemotherapy drugs is to be made available on NHS for [...]

New Study Could Help in Personalizing Lung Cancer Treatment

Lung Cancer Treatment
Researchers at the University of Copenhagen have used highly sophisticated molecular analyzes for the purpose of identifying key proteins that signal pathways [...]

Researchers Link Genetic Mutations to Improved Outcomes in Lung Cancer Patients

Non-Small-Cell Lung Cancer (NSCLC)
Researchers have presented new findings related to lung cancer at the European Society for Medical Oncology (ESMO) conference in Barcelona, Spain. These new [...]

Considering Unique Cancer Traits for Targeted Therapies

Doctor Patient
Lung cancer researchers Dr Kate Sutherland and Dr Sarah Best from the Walter and Eliza Hall Institute led the research and it has been published in Nature [...]